Correlation of contrast-enhanced MR images with the histopathology of minimally invasive thermal and cryoablation cancer treatments in normal dog prostates

Magnetic Resonance Imaging (MRI) is a promising tool for visualizing the delivery of minimally invasive cancer treatments such as high intensity ultrasound (HUS) and cryoablation. We use an acute dog prostate model to correlate lesion histopathology with contrast-enhanced (CE) T1 weighted MR images, to aid the radiologists in real time interpretation of in vivo lesion boundaries and pre-existing lesions. Following thermal or cryo treatments, prostate glands are removed, sliced, stained with the vital dye triphenyl tetrazolium chloride, photographed, fixed and processed in oversized blocks for routine microscopy. Slides are scanned by Trestle Corporation at .32 microns/pixel resolution, the various lesions traced using annotation software, and digital images compared to CE MR images. Histologically, HUS results in discrete lesions characterized by a "heat-fixed" zone, in which glands subjected to the highest temperatures are minimally altered, surrounded by a rim or "transition zone" composed of severely fragmented, necrotic glands, interstitial edema and vascular congestion. The "heat-fixed" zone is non-enhancing on CE MRI while the "transition zone" appears as a bright, enhancing rim. Likewise, the CE MR images for cryo lesions appear similar to thermally induced lesions, yet the histopathology is significantly different. Glands subjected to prolonged freezing appear totally disrupted, coagulated and hemorrhagic, while less intensely frozen glands along the lesion edge are partially fragmented and contain apoptotic cells. In conclusion, thermal and cryo-induced lesions, as well as certain pre-existing lesions (cystic hyperplasia - non-enhancing, chronic prostatitis - enhancing) have particular MRI profiles, useful for treatment and diagnostic purposes.

[1]  R. Stafford,et al.  Transurethral ultrasound applicators with directional heating patterns for prostate thermal therapy: in vivo evaluation using magnetic resonance thermometry. , 2004, Medical physics.

[2]  James E. Coad,et al.  Histologic differences between cryothermic and hyperthermic therapies , 2003, SPIE BiOS.

[3]  Chris J Diederich,et al.  MRI‐guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator , 2002, Journal of magnetic resonance imaging : JMRI.

[4]  Shunyou Wang,et al.  Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Bingham Role of vascular function in response of tumors in vivo to hyperthermia , 1980 .

[6]  J. Chapelon,et al.  Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. , 1993, Journal of endourology.

[7]  Chris J Diederich,et al.  Curvilinear transurethral ultrasound applicator for selective prostate thermal therapy. , 2005, Medical physics.

[8]  M. Marberger,et al.  Morphology of tissue destruction induced by focused ultrasound. , 1993, European urology.

[9]  M Paley,et al.  Laser therapy for breast cancer: MR imaging and histopathologic correlation. , 1996, Radiology.

[10]  D. Theodorescu Cancer cryotherapy: evolution and biology. , 2004, Reviews in urology.

[11]  D. Bostwick,et al.  Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia. , 1996, Urology.

[12]  T. Sielaff,et al.  Radiofrequency ablation causes ‘thermal fixation’ of hepatocellular carcinoma: a post‐liver transplant histopathologic study , 2003, Clinical transplantation.

[13]  Transurethral hyperthermia for benign prostatic hyperplasia patients with retention. , 1992, The Journal of urology.

[14]  B. Daniel,et al.  MRI-guided interstitial ultrasound thermal therapy of the prostate: a feasibility study in the canine model. , 2005, Medical physics.

[15]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[16]  David L Wilson,et al.  Radiofrequency thermal ablation: Correlation of hyperacute MR lesion images with tissue response , 2004, Journal of magnetic resonance imaging : JMRI.

[17]  Sharon L. Thomsen,et al.  Mapping of thermal injury in biologic tissues using quantitative pathologic techniques , 1999, Photonics West - Biomedical Optics.

[18]  N. Sanghvi,et al.  Noninvasive ultrasonic subtotal ablation of the prostate in dogs. , 1996, American journal of veterinary research.

[19]  Peter Alken,et al.  Extracorporeal application of high‐intensity focused ultrasound for prostatic tissue ablation , 2005, BJU international.

[20]  K. Vigen,et al.  In vivo MR thermometry of frozen tissue using R2* and signal intensity. , 2005, Academic radiology.

[21]  J. Patterson,et al.  The role of blood flow in hyperthermia. , 1979, International journal of radiation oncology, biology, physics.

[22]  J C Bischof,et al.  In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia , 2004, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[23]  D. Bostwick,et al.  Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications. , 2003, The Journal of urology.

[24]  Chris J Diederich,et al.  Highly directional transurethral ultrasound applicators with rotational control for MRI-guided prostatic thermal therapy. , 2004, Physics in medicine and biology.